Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05185492 · ClinicalTrials.gov registry record
Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock
A clinical trial of Acute Myocardial Infarction and Cardiogenic Shock, sponsored by Stavros G Drakos.
- Recruiting
- Registry status
- 500
- Enrollment target
- 3
- Study locations
NCT05185492 is a study of Acute Myocardial Infarction and Cardiogenic Shock that is actively recruiting participants, run by Stavros G Drakos. The registered enrollment target is 500 participants, below the 1,856-participant average among 19 other Acute Myocardial Infarction trials with a reported enrollment target (73% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT05185492, a study of Acute Myocardial Infarction and Cardiogenic Shock, is actively recruiting participants, sponsored by Stavros G Drakos.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 3
- Study locations
Study Summary
This large real-world international prospective registry will provide a unique opportunity to comprehensively understand the contemporary management, clinical course and short as well as long-term outcomes of all Cardiogenic Shock (CS) patients cared for at four high volume dedicated shock care centers. As the first true North American multicenter CS collaborative with a uniform dedicated and comprehensive case report form, the high patient volumes and wide spectrum of clinical acuity seen at these institutions will provide valuable insight into the factors associated with adverse outcomes; and will serve as a blueprint for future clinical trial designs that may better inform clinical practice.
Conditions Studied
Study Locations (3)
Florida
- Cleveland Clinic Florida - Weston
Virginia
- Inova Heart and Vascular Institute - Falls Church
Ontario
- University of Toronto - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2022-05-25 |
| Est. Completion | 2027-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05185492
The ClinicalTrials.gov registry entry for NCT05185492 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,856-participant average among 19 other Acute Myocardial Infarction trials with a reported enrollment target (73% lower). The listed sponsor is Stavros G Drakos, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Acute Myocardial Infarction appearing as the primary indexed condition, and to 0 interventions.
NCT05185492 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, Virginia, Ontario.
Frequently Asked Questions
What is clinical trial NCT05185492 about?
NCT05185492 is a clinical study titled "Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock". This large real-world international prospective registry will provide a unique opportunity to comprehensively understand the contemporary management, clinical course and short as well as long-term outcomes of all Cardiogenic Shock (CS) patients cared for at four high volume dedicated shock care cent...
What is the current status of trial NCT05185492?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2022-05-25. Estimated completion is 2027-12-31.
What conditions does trial NCT05185492 study?
This clinical trial studies the following conditions: Acute Myocardial Infarction, Cardiogenic Shock.
Who is sponsoring clinical trial NCT05185492?
This trial is sponsored by Stavros G Drakos, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05185492 being conducted?
This trial has 3 study locations across Florida, Virginia, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Myocardial Infarction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard.
RECRUITING · NA
-
Abbott Vascular Medical Device Registry
RECRUITING
-
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
RECRUITING · NA
-
Arrhythmia Detection After MI
RECRUITING · NA
-
COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial
ACTIVE NOT RECRUITING
-
Molecular and Morphologic Characterization of Circulating Endothelial Cells
ACTIVE NOT RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.